Lombardi Comprehensive Cancer Center, Georgetown — Washington D.C., District of Columbia

Lombardi Comprehensive Cancer Center, Georgetown is a clinical research site located in Washington D.C., District of Columbia, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center, Georgetown has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center, Georgetown?

Lombardi Comprehensive Cancer Center, Georgetown has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center, Georgetown conducted?

Lombardi Comprehensive Cancer Center, Georgetown has 1 clinical trials on record. Their work covers Solid Tumors.

Is Lombardi Comprehensive Cancer Center, Georgetown accredited by Crixeo Health?

Lombardi Comprehensive Cancer Center, Georgetown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center, Georgetown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.